4//SEC Filing
ANDERSON ELIZABETH M 4
Accession 0001567619-22-013109
CIK 0001628171other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:04 PM ET
Size
7.8 KB
Accession
0001567619-22-013109
Insider Transaction Report
Form 4
ANDERSON ELIZABETH M
Director
Transactions
- Award
Common Stock
2022-06-16+5,200→ 10,625 total - Award
Stock Option (Right to Buy)
2022-06-16+18,400→ 18,400 totalExercise: $16.80Exp: 2032-06-15→ Common Stock (18,400 underlying)
Holdings
- 26,990(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by David W. Anderson 1996 Irrevocable Trust.
- [F2]Includes 5,200 Restricted Stock Units.
- [F3]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 16, 2022 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001758247
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:04 PM ET
- Size
- 7.8 KB